相关实验视频

Updated: May 15, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.1K

LRG1,一种用于IMCD疾病活动的新型血清生物标志物

Miao-Yan Zhang1, Zi-Han Yang1, Yu-Chong Qiu1

  • 1Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 ShuaifuyuanNo. 1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China.

Biomarker research
|April 8, 2025
PubMed

Insights

富含白的α-2-甘氨蛋白-1 (LRG1) 显示出作为异常多中心卡斯特曼病 (iMCD) 的生物标志物具有前途. 较低的LRG1水平表明iMCD患者的治疗反应是积极的.

科学领域:

  • 生物化学 生物化学
  • 免疫学 免疫学 免疫学
  • 蛋白质组学是指蛋白质组学.

背景情况:

  • 异常多中心卡斯特曼病 (iMCD) 是一种罕见的淋巴增殖性疾病,具有系统性炎症和多器官功能障碍.
  • 目前对IMCD的治疗反应评估由于临床异质性而缺乏敏感性.
  • 细胞因子风暴驱动iMCD的病变发生.
抽象的

No abstract available in PubMed .

关键词:
生物标志物生物标志物异形多中心卡斯特曼病 (iMCD)富含白的α-2-糖蛋白-1 (LRG1) 是一种含有白的蛋白质.蛋白质组学是指蛋白质组学.

更多相关视频

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

16.6K
High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

15.8K

相关概念视频